AZN Astrazeneca Plc

FRANKFURT--The following is a summary of analysts' forecasts for Astrazeneca plc (AZN) second-quarter results, based on a poll of seven analysts conducted by Dow Jones Newswires (figures in million dollars, EPS and dividend in dollar, target price in pence, according to IFRS). Earnings figures are scheduled to be released July 28.

=== 
                  Sales:       Seroquel 
2nd Quarter       Total   Nexium    XR  Symbicort  Crestor 
AVERAGE           5,452     474    219       793    1,035 
Prev. Year        5,836     647    264       842    1,310 
+/- in %           -6.6     -27    -17      -5.8      -21 
 
MEDIAN            5,516     468    223       792    1,042 
Maximum           5,622     499    230       826    1,099 
Minimum           5,275     456    192       765      935 
Amount                7       6      6         5        7 
 
Berenberg         5,622     469    226        --    1,097 
Bernstein         5,326     466    192       782      988 
Cowen and Company 5,275     465    230       765    1,010 
Deutsche Bank     5,551     499    227       792    1,042 
Jefferies         5,328     456    220       802      935 
JP Morgan         5,516      --     --        --    1,076 
Morgan Stanley    5,547     486    218       826    1,099 
 
                   Core:               Net 
                   Operat.          attrib. 
2nd Quarter         profit    PBT   profit     EPS 
AVERAGE              1,342  1,188      997    0.79 
Prev. Year           1,813  1,679    1,520    1.21 
+/- in %               -26    -29      -34  -35 
 
MEDIAN               1,320  1,155      989    0.78 
Maximum              1,443  1,327    1,108    0.88 
Minimum              1,284  1,114      935    0.74 
Amount                   7      5        6    6 
 
Berenberg            1,443  1,327    1,108    0.88 
Bernstein            1,284  1,114      935    0.74 
Cowen and Company    1,300  1,135      942    0.75 
Deutsche Bank        1,320  1,155      964    0.76 
Jefferies            1,380  1,208    1,013    0.80 
JP Morgan            1,300     --       --      -- 
Morgan Stanley       1,367     --    1,018    0.81 
 
            Target price  Rating                 DPS 2016 
AVERAGE            5,025  positive 4     AVERAGE     2.80 
Prev. Quarter      4,625  neutral  4     Prev. Year  2.80 
+/- in %            +8.6  negative 0     +/- in %     0.0 
 
MEDIAN             4,900                 MEDIAN      2.80 
Maximum            5,800                 Maximum     2.80 
Minimum            4,352                 Minimum     2.80 
Amount                 6                 Amount         5 
 
Berenberg          5,400  Buy                        2.80 
Bernstein          4,352  Market perform               -- 
Bryan Garnier         --  Buy                          -- 
Cowen and Company     --  Market perform             2.80 
Deutsche Bank      5,800  Buy                        2.80 
Jefferies          4,800  Hold                       2.80 
JP Morgan          4,800  Neutral                      -- 
Morgan Stanley     5,000  Overweight                 2.80 
=== 

Year-earlier figures are as reported by the company.

DJG/mus 

(END) Dow Jones Newswires

July 25, 2016 10:51 ET (14:51 GMT)

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024